Timeline for Approval for non-mRNA COVID-19 Vaccines to be Included in National Vaccination Programme

Mr Leong Mun Wai asked the Minister for Health what is the timeline for the approval status for non-mRNA COVID-19 vaccines, such as SinoPharm and AstraZeneca, to be included into the national vaccination programme under the Pandemic Special Access Route.

Mr Ong Ye Kung: I thank the Member for his question. I have addressed it in my reply to Question No 72 for oral answer on the Order Paper for 1 November 2021. [Please refer to "Assessment Criteria for Sinovac and Sinopharm COVID-19 Vaccines for Inclusion in National Vaccination Programme", Official Report, 1 November 2021, Vol 95, Issue 41, Written Answers to Questions for Oral Answer Not Answered by End of Question Time section.]